ArticleJournal of hematology & oncology2024
A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Hisashi Ishida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.